Stock Analysis
- Japan
- /
- Healthcare Services
- /
- TSE:6062
Charm Care Third Quarter 2024 Earnings: EPS: JP¥22.14 (vs JP¥11.71 in 3Q 2023)
Charm Care (TSE:6062) Third Quarter 2024 Results
Key Financial Results
- Revenue: JP¥11.0b (up 44% from 3Q 2023).
- Net income: JP¥723.0m (up 89% from 3Q 2023).
- Profit margin: 6.6% (up from 5.0% in 3Q 2023). The increase in margin was driven by higher revenue.
- EPS: JP¥22.14 (up from JP¥11.71 in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Charm Care Earnings Insights
Looking ahead, revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Healthcare industry in Japan.
Performance of the Japanese Healthcare industry.
The company's shares are up 15% from a week ago.
Risk Analysis
Before you take the next step you should know about the 1 warning sign for Charm Care that we have uncovered.
Valuation is complex, but we're helping make it simple.
Find out whether Charm Care is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:6062
Adequate balance sheet and fair value.